Sentio Biosciences is happy to share our over 15-year journey of innovation and commercial manufacturing of drug products, Active Pharmaceutical Ingredients (API), and Key Starting Materials (KSM) at our cGMP facility in Maryland Heights, St. Louis, Missouri. -Our mission is to provide quality, compliant, and safe products for our customers. -Our offerings include CDMO services, Essential medicines, and Innovation Development & Licensing. -Our experienced team has expertise in delivering products from development to commercial manufacturing. Thank you for your collaboration and support in our journey! Learn more at: https://lnkd.in/gN6KPCfk #SentioTeam #SentioPartners #BioMap #STLMade #PublicPrivatePartnerships #USAManufacturing #AdvancedManufacturing #Onshoring #Americanmademedicines #Americaninnovation #PharmaceuticalManufacturing #SupplyChainResilence #Generic #Impossibleispossible #Healthsecurity #Economicgrowth BioSpace Missouri Partnership Missouri Department of Economic Development API Innovation Center American Medical Manufacturers Association (AMMA) Alliance for Building Better Medicine Association for Accessible Medicines BioMap BioSTL Missouri Department of Economic Development Missouri Association of Manufacturers Missouri Chamber of Commerce and Industry U.S. Economic Development Administration Us Department Of Commerce
Sentio BioSciences LLC
制药业
Maryland Heights,Missouri 334 位关注者
CDMO Focused on Innovation, cGMP Advanced Manufacturing and Commercialization of API and Drug Products.
关于我们
We are a CDMO focused on advanced pharmaceutical development, manufacturing and commercialization of Complex Pharmaceutical Molecules, High Potency molecules, and Toxic Substances in highly contained environment, using Advanced Manufacturing Techniques like Flow Chemistry, Continuous Manufacturing, and Batch Manufacturing where appropriate. We manufacture KSMs, APIs, Drug Products at pilot, clinical & commercial population scale. Our capabilities include completing all aspects needed for API DMF & Drug Product FDA registration. Our facility & systems are cGMP compliant & audited by the FDA every 2 years.
- 网站
-
https://www.sentiobiosciences.com/
Sentio BioSciences LLC的外部链接
- 所属行业
- 制药业
- 规模
- 11-50 人
- 总部
- Maryland Heights,Missouri
- 类型
- 私人持股
- 创立
- 2008
地点
-
主要
218 Millwell Dr
Suite A, B and C
US,Missouri,Maryland Heights,Headquarters
Sentio BioSciences LLC员工
动态
-
Our CEO Karthik Raghavan will be on the #STLTechWeek panel discussion "Optimizing BioPharma Manufacturing: The intersection of innovation & Infrastructure" on April 3rd. Come join us at this event!
#STLTechWeek is hosting "Breakthrough: A Health Innovation Symposium" on April 3rd at T-REX in Downtown with a free full-day lineup of St. Louis experts talking #biotech and #healthtech - https://lnkd.in/g4ZRQXA5 At Breakthrough, we will hear from the Opening Panel discussion moderated by Kevin Webb, Chief Operating Officer at API Innovation Center, along with panelists Karthik Raghavan, CEO at Sentio BioSciences LLC, Haitao Li, Professor and Chair at University of Missouri-Saint Louis, and Gregg Dougan, Senior Director of Sustainability & Emerging Technologies, Experitec Inc. ?? "Optimizing BioPharma Manufacturing: The Intersection of Innovation and Infrastructure" As the pharmaceutical industry evolves, ensuring a resilient, efficient, and scalable biopharma manufacturing ecosystem is critical for national health security. This panel, led by APIIC, brings together experts from academia, industry, and advanced manufacturing to discuss how cutting-edge technologies, strategic public-private partnerships, and infrastructure optimization are shaping the future of drug production. With a mission to strengthen the U.S. pharmaceutical supply chain, APIIC plays a pivotal role in uniting government agencies, research institutions, and manufacturers to accelerate novel pharmaceutical manufacturing solutions. Panelists will explore the latest advancements in continuous manufacturing, automation, and AI-driven process optimization, along with strategies to maximize the potential of underutilized facilities to expand domestic production capacity ?? Register for Breakthrough: https://lnkd.in/g4ZRQXA5
-
-
? Exciting Opportunity at the Global Trade Compliance Briefing! ? Today, I had the incredible opportunity, through Sentio BioSciences LLC , to attend the Global Trade Compliance Briefing at the World Trade Center St. Louis , in partnership with the Missouri District Export Council. ?? Navigating the Evolving Landscape of International Trade Compliance: As international trade regulations continue to evolve, staying compliant has never been more challenging. ?? Key Compliance Challenges: ?? Keeping up with constantly shifting trade laws. ?? Managing conflicting regulations across regions. ?? Navigating complex tariff structures and changing duty rates. ?? Sanctions & Embargoes: Enforced under laws such as the Trading with the Enemy Act (TWEA) and International Emergency Economic Powers Act (IEEPA), with enforcement by the Office of Foreign Assets Control (OFAC) and the Bureau of Industry and Security (BIS). ?? Export Controls: Regulated under the Export Administration Regulations (EAR) and the International Traffic in Arms Regulations (ITAR). ?? Key Tariff & Risk Considerations ?? Changes to tariffs—especially those targeting China , Mexico, and Canada —have significant implications for pricing and supply chains. ?? Section 301 : New tariffs and trade restrictions impact specific goods and can disrupt supply chains. ?? Intellectual Property Enforcement (Section 337): Counterfeit and infringing goods face stricter import restrictions. ?? Impact on the Pharmaceutical Industry The pharmaceutical industry faces unique challenges in import compliance, including: ?? Accurate product classification under the Harmonized Tariff System (HTS). ?? Correct customs valuation, as duties are based on product value. ?? Ensuring "reasonable care" in classifying goods to avoid costly penalties. ?? Duty Mitigation Strategies ?? First Sale Rule: Assessing duty based on the first transaction price may help save costs. ?? Bonded Warehouses & FTZs: Can help defer or reduce duty payments. ?? Duty Drawback & Section 321 De Minimis Exemptions: Opportunities for refunds on exported goods and low-value shipments. ?? Non-Compliance Risks ?? Fraud penalties can be severe, with fines ranging from 5-8 times the total duty loss. ? Gross negligence can lead to significant financial and operational disruptions. ? Accurate classification under HTS codes is crucial to avoid unexpected duties and penalties. ?? Exploring duty mitigation strategies such as bonded facilities and FTZs could help optimize import costs. ??? Proactive risk assessments on Section 301 tariffs and IEEPA actions will be essential in managing raw material sourcing. As we navigate this complex landscape, staying informed and agile will be key to mitigating risks and optimizing compliance. ?? #InternationalTrade ?? #TradeCompliance ? #Tariffs ?? #GlobalTrade ?? #ImportExport ???? #Customs ?? #Pharmaceuticals ?? #Regulations ?? #BusinessStrategy ??#sentiobiosciences
-
-
Missouri’s collaborative innovation ecosystem is setting a national example for reshoring pharmaceutical manufacturing and strengthening the U.S. pharmaceutical supply chain.??? Learn more ?? https://lnkd.in/gXsCs43J #PharmaceuticalInnovation #APImanufacturing #Missouri #HealthcareReshoring #Biopharma #SupplyChainSecurity
-
Congratulations James Macon on your semi-retirement! Enjoy your vacation and happy you will continue working with us part-time. Your work ethics, attitude and teamwork are very much appreciated! You are Sentio! #SentioTeam #STLMade #USAManufacturing #AdvancedManufacturing #Onshoring #Americanmademedicines #Americaninnovation #PharmaceuticalManufacturing #SupplyChainResilence #Generic #Impossibleispossible #Healthsecurity #Economicgrowth Sentio BioSciences LLC
-
-
Congratulations to?API Innovation Center?and the?University of Missouri-Saint Louis?on the opening of the new Research and Development lab. Sentio is excited to be part of this collaboration, as more Missouri pharmaceutical companies take the lead on critical drug molecule development & manufacturing to improve availability and supply chain resilience efforts. #SentioTeam #SentioPartners #STLMade #PublicPrivatePartnerships #USAManufacturing #AdvancedManufacturing #Onshoring #Americanmademedicines #Americaninnovation #PharmaceuticalManufacturing #SupplyChainResilence #Generic #Impossibleispossible #Healthsecurity #Economicgrowth Kristin Sobolik Anthony Sardella Christopher S. Brian Williams
-
-
Sentio is a full service CDMO with development & manufacturing in Missouri USA & can support your company needing compliance with the BioSecure Act. #Sentio #MadeInUSA #stlmade #onshoring #PharmaceuticalManufacturing #USCDMO
Outsourced Pharma Live ??? Speaker Spotlight: Robert Discordia, PhD brings a deep and diverse set of capabilities from his more than 30 years in the pharma and biotech industry, from drug discovery to non-clinical and clinical development to commercial manufacturing.?Bob had a distinguished career with Bristol-Myers Squibb which spanned 26 years, and he is the Co-Founder, President & CEO of EQUULUS Therapeutics. Watch Dr. Discordia and other supply chain experts discuss the BIOSECURE Act's impact on outsourcing during our virtual event on February 26th: https://lnkd.in/eC6zKu7f
-
-
The Missouri Times spoke with the API Innovation Center about our efforts to bolster domestic pharmaceutical manufacturing and strengthen national health security by reducing reliance on foreign manufacturing. With support from the state of Missouri, we are utilizing innovative advanced manufacturing technologies to improve the quality and efficiency of drug manufacturing, all while bringing jobs and investment back to the state. Read the full article on our website: https://lnkd.in/ebNrSA9f #Missouri #PharmaceuticalManufacturing #APIInnovationCenter #AdvancedManufacturing #HealthSecurity
-
Sentio is hiring! Quality Assurance Specialist II (QC Compliance) https://lnkd.in/gKWi3kfA ?Apply on Indeed.
-
Sentio is hiring! Pharmaceutical Quality Control Analyst II Apply on https://lnkd.in/gnQFafsN